MD Anderson President Ron DePinho, M.D., has been inducted as a new fellow of the American Association for Cancer Research (AACR) Academy. He joins 10 other cancer leaders as new inductees in the prestigious academy, which recognizes those who’ve made significant contributions to cancer research.
All fellows are nominated and elected through a rigorous peer review process conducted by existing AACR members and ratified by its executive committee. This process involves an assessment of each candidate’s scientific achievements in cancer research and cancer-related biomedical science.
“Our 2015 class of fellows includes 11 luminaries in the cancer research field, in honor of the 11 founders of the AACR in 1907,” says Margaret Foti, M.D., Ph.D., AACR chief executive officer. “We’re delighted to recognize the incredible scientific accomplishments of these illustrious researchers and celebrate how their dedicated efforts have helped accelerate the pace of progress against many of the hundreds of diseases we collectively call cancer.” According to the AACR, this “brain trust” of global leaders in cancer research offers invaluable insight into the future of cancer research and patient care, and continues to work with the AACR in its mission to prevent and cure all cancers.
“Dr. DePinho’s outstanding work in basic and translational research in cancer, aging and age-associated degenerative disorders has been internationally recognized,” says The University of Texas System Chancellor William H. McRaven. “His selection as a member of this notable academy is further testament to his significant contributions to cancer science.”
DePinho joins seven other MD Anderson faculty members who’ve previously been named to the academy. They are James Allison, Ph.D., Isaiah Fidler, Ph.D., D.V.M., Emil Freireich, M.D., Waun Ki Hong, M.D., V. Craig Jordan, Ph.D., Margaret Kripke, Ph.D., John Mendelsohn, M.D., and Louise Strong, M.D.